A detailed history of Comerica Securities,Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Comerica Securities,Inc. holds 6,043 shares of AZN stock, worth $470,870. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,043
Previous 6,307 4.19%
Holding current value
$470,870
Previous $451,000 9.31%
% of portfolio
0.03%
Previous 0.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

SELL
$64.85 - $71.7 $17,120 - $18,928
-264 Reduced 4.19%
6,043 $409,000
Q2 2023

Aug 04, 2023

SELL
$69.91 - $75.81 $29,222 - $31,688
-418 Reduced 6.22%
6,307 $451,000
Q1 2023

Apr 27, 2023

BUY
$63.15 - $71.6 $66,244 - $75,108
1,049 Added 18.48%
6,725 $466,000
Q4 2022

Feb 10, 2023

BUY
$54.21 - $70.44 $14,961 - $19,441
276 Added 5.11%
5,676 $384,000
Q3 2022

Nov 07, 2022

BUY
$53.02 - $135.75 $86,846 - $222,358
1,638 Added 43.54%
5,400 $296,000
Q2 2022

Jul 19, 2022

SELL
$59.26 - $71.14 $106,134 - $127,411
-1,791 Reduced 32.25%
3,762 $249,000
Q1 2022

Apr 28, 2022

SELL
$55.72 - $67.12 $12,982 - $15,638
-233 Reduced 4.03%
5,553 $368,000
Q4 2021

Feb 10, 2022

BUY
$54.02 - $63.83 $12,586 - $14,872
233 Added 4.2%
5,786 $337,000
Q3 2021

Nov 10, 2021

SELL
$55.56 - $60.79 $6,444 - $7,051
-116 Reduced 2.05%
5,553 $334,000
Q2 2021

Aug 11, 2021

SELL
$48.42 - $60.18 $27,405 - $34,061
-566 Reduced 9.08%
5,669 $340,000
Q1 2021

May 12, 2021

BUY
$47.16 - $54.44 $294,042 - $339,433
6,235 New
6,235 $310,000
Q4 2020

Feb 09, 2021

SELL
$48.52 - $58.02 $246,918 - $295,263
-5,089 Closed
0 $0
Q3 2020

Nov 04, 2020

SELL
$53.07 - $61.1 $14,116 - $16,252
-266 Reduced 4.97%
5,089 $279,000
Q2 2020

Jul 17, 2020

SELL
$43.1 - $55.31 $12,671 - $16,261
-294 Reduced 5.2%
5,355 $283,000
Q1 2020

Apr 16, 2020

SELL
$37.79 - $51.33 $53,699 - $72,939
-1,421 Reduced 20.1%
5,649 $252,000
Q4 2019

Feb 11, 2020

SELL
$42.46 - $50.46 $8,152 - $9,688
-192 Reduced 2.64%
7,070 $353,000
Q3 2019

Oct 15, 2019

SELL
$40.12 - $45.47 $14,122 - $16,005
-352 Reduced 4.62%
7,262 $324,000
Q3 2019

Oct 15, 2019

BUY
$40.12 - $45.47 $60,581 - $68,659
1,510 Added 24.74%
7,614 $289,000
Q2 2019

Aug 09, 2019

BUY
$37.28 - $41.68 $21,510 - $24,049
577 Added 10.44%
6,104 $252,000
Q1 2019

May 07, 2019

BUY
$35.49 - $43.02 $196,153 - $237,771
5,527 New
5,527 $223,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $241B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Comerica Securities,Inc. Portfolio

Follow Comerica Securities,Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comerica Securities,Inc. with notifications on news.